CBC Reference Ranges: Difference between revisions
updated RET reference interval |
mNo edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
|'''HCT Female (Ratio)''' | |'''HCT Female (Ratio)''' | ||
|'''HCT Male (Ratio)''' | |'''HCT Male (Ratio)''' | ||
|''' | |'''RBC Female''' | ||
|''' | |'''RBC Male''' | ||
|'''MCV (fL)''' | |'''MCV (fL)''' | ||
|'''MCH (pg)''' | |'''MCH (pg)''' | ||
|'''MCHC''' | |'''MCHC (g/L)''' | ||
|'''RDW''' | |'''RDW (%CV)''' | ||
|'''Platelets (x10<sup>9</sup>/L)''' | |'''Platelets (x10<sup>9</sup>/L)''' | ||
|- | |- | ||
| Line 27: | Line 27: | ||
|- | |- | ||
|'''Cord''' | |'''Cord''' | ||
| | |124-192 | ||
| | |124-192 | ||
| | |0.37-0.56 | ||
| | |0.37-0.56 | ||
| | |3.53-5.52 | ||
| | |3.53-5.52 | ||
| | |99-119 | ||
| | |32-39 | ||
| | |305-345 | ||
| | |15.2-19.0 | ||
| | |150-400 | ||
|- | |- | ||
|'''1 month''' | |'''1 month''' | ||
| | |93-158 | ||
| | |93-158 | ||
| | |0.27-0.46 | ||
| | |0.27-0.46 | ||
| | |2.9-4.8 | ||
| | |2.9-4.8 | ||
| | |89-100 | ||
| | |28-34 | ||
| | |324-364 | ||
| | |13.2-17.5 | ||
| | |150-650 | ||
|- | |- | ||
|'''2-3 months''' | |'''2-3 months''' | ||
| | |97-130 | ||
| | |97-130 | ||
| | |0.29-0.38 | ||
| | |0.29-0.38 | ||
| | |3.3-4.8 | ||
| | |3.3-4.8 | ||
| | |72-91 | ||
| | |24-32 | ||
| | |323-361 | ||
| | |11.9-16.2 | ||
| | |150-650 | ||
|- | |- | ||
|'''4-11 months''' | |'''4-11 months''' | ||
| | |105-136 | ||
| | |105-136 | ||
| | |0.31-0.40 | ||
| | |0.31-0.40 | ||
| | |4.0-5.3 | ||
| | |4.0-5.3 | ||
| | |69-84 | ||
| | |22-29 | ||
| | |315-353 | ||
| | |12.0-16.0 | ||
| | |150-575 | ||
|- | |- | ||
|'''1-3 years''' | |'''1-3 years''' | ||
| | |105-140 | ||
| | |105-140 | ||
| | |0.32-0.41 | ||
| | |0.32-0.41 | ||
| | |4.0-5.4 | ||
| | |4.0-5.4 | ||
| | |70-86 | ||
| | |23-29 | ||
| | |317-353 | ||
| | |12-15.5 | ||
| | |150-500 | ||
|- | |- | ||
|'''4-7 years''' | |'''4-7 years''' | ||
| | |113-145 | ||
| | |113-145 | ||
| | |0.33-0.42 | ||
| | |0.33-0.42 | ||
| | |4.1-5.4 | ||
| | |4.1-5.4 | ||
| | |74-87 | ||
| | |24-29 | ||
| | |319-353 | ||
| | |12-14.5 | ||
| | |150-475 | ||
|- | |- | ||
|'''8-12 years''' | |'''8-12 years''' | ||
| | |115-145 | ||
| | |115-145 | ||
| | |0.35-0.43 | ||
| | |0.35-0.43 | ||
| | |4.2-5.6 | ||
| | |4.2-5.6 | ||
| | |75-90 | ||
| | |24-30 | ||
| | |315-350 | ||
| | |12-14.5 | ||
| | |150-425 | ||
|- | |- | ||
|'''13-15 years''' | |'''13-15 years''' | ||
| | |115-150 | ||
| | |125-160 | ||
| | |0.35-0.44 | ||
| | |0.37-0.47 | ||
| | |4-5.35 | ||
| | |4.4-5.7 | ||
| | |78-93 | ||
| | |25-31 | ||
| | |315-350* | ||
| | |12.0-14.5 | ||
| | |150-400 | ||
|- | |- | ||
|'''16+ (Adult)''' | |'''16+ (Adult)''' | ||
| | |115-155 | ||
| | |130-175 | ||
| | |0.35-0.46 | ||
| | |0.40-0.52 | ||
| | |3.6-5.6 | ||
| | |4.3-6.0 | ||
| | |80-99 | ||
| | |27-33 | ||
| | |300-365 | ||
| | |11.5-15.0 | ||
| | |150-400 | ||
|} | |} | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 226: | Line 226: | ||
|} | |} | ||
'''*''' MCHC 13-15 years: Female 315-350 Male 318-353 | '''*''' MCHC 13-15 years: Female 315-350 Male 318-353 | ||
'''Reticulocytes (x 10<sup>9</sup>/L)''' | '''Reticulocytes (x 10<sup>9</sup>/L)''' | ||
Adult 10 - 100 | Adult 10 - 100 | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
!ESR | !ESR | ||
! | ! | ||
! | |||
! | |||
|- | |||
|'''Male''' | |||
| | |||
|'''Female''' | |||
| | |||
|- | |- | ||
| | |≤20 years | ||
| | |<10 mm/hr | ||
|≤20 years | |||
|<10 mm/hr | |||
|- | |- | ||
| | |21-50 years | ||
| | |<20 mm/hr | ||
|21-50 years | |||
|<25 mm/hr | |||
|- | |- | ||
|51- | |>51 years | ||
| | |<25 mm/hr | ||
|51-65 years | |||
|<30 mm/hr | |||
|- | |- | ||
| | | | ||
| | | | ||
|>66 years | |||
|<40 mm/hr | |||
|} | |} | ||
<small>References:</small> | |||
<small>Northern Haematology Quality Assurance Group. (2017). ''Consensus guidelines: Haematology reference ranges'' (Version 1.0).</small> | |||